🩹 Healing & RecoveryPreclinical

Pentadeca Arginate

PDA · BPC-157 Arginate · Arginine-enhanced BPC-157

An arginine-enhanced BPC-157 analog studied for enhanced bioavailability and tissue repair

Typical Dose

500 mcg once daily

Route

Subcutaneous

Frequency

Once or twice daily

Cycle

4-12 weeks

Pentadeca Arginate peptide hero image

Overview

Pentadeca Arginate (PDA) is a synthetic peptide representing an arginine-enhanced version of BPC-157. It contains the same core pentadecapeptide sequence as BPC-157 but with arginine modifications proposed to enhance stability, bioavailability, and receptor binding. Early data suggests it may offer improved efficacy compared to standard BPC-157 for tissue repair, gut healing, and musculoskeletal recovery.

Key Benefits

Enhanced tissue repair vs. standard BPC-157 (proposed)
Improved bioavailability
Gut healing and intestinal permeability repair
Tendon and ligament recovery
Anti-inflammatory effects
Neuroprotection

Mechanism of Action

Like BPC-157, PDA acts through multiple pathways including upregulation of growth factors (VEGF, EGF), promotion of angiogenesis, and modulation of the nitric oxide system. The arginine modification is proposed to enhance NO (nitric oxide) production, which may amplify its vasodilatory and healing effects.

Dosing Protocol

Typical Dose

500 mcg once daily

Dose Range

250-1000 mcg/day

Frequency

Once or twice daily

Route

Subcutaneous injection near injury site

Cycle Length

4-12 weeks

CLINICAL NOTES

Similar dosing to BPC-157. Inject near the injury site for localized healing effects. Can be combined with TB-500 for comprehensive healing.

Save to Library

Reconstitution calculator and cycle planner pre-filled with Pentadeca Arginate defaults

Side Effects & Safety

Generally well tolerated
Mild nausea (rare)
Injection site reactions
Limited long-term safety data

IMPORTANT DISCLAIMER

This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.

Research References

Common Stacks

PDA is increasingly used as a BPC-157 alternative or complement, especially for gut and systemic inflammation.

Frequently Asked Questions

Quick Reference

CategoryHealing & Recovery
Research StatusPreclinical
Typical Dose500 mcg once daily
RouteSubcutaneous
Cycle4-12 weeks
Opens a print dialog. Choose Save as PDF as the destination to download a clean one-page PDF.

Community Reviews

Real experiences from the Peptide Insights community

Have you used Pentadeca Arginate?

Real experiences from real people help others make informed decisions. Share what worked, what didn't, and what you wish you'd known before starting.

Dosing insightsResults timelineSide effectsStack combinations
Sign In to Share Your Experience

Free account required. Your review helps the Peptide Insights community.

No reviews yet for Pentadeca Arginate

Be the first to share your experience. Your insight could help someone else decide if Pentadeca Arginate is right for them.

Sign In to Be the First
Free Guide

Want to go deeper on Pentadeca Arginate?

Get our free 32-page Beginner's Guide — plain-language breakdowns of the top peptides, dosing essentials, and safety basics.

Free Beginner's Guide

32-page PDF, instant download

No spam. Unsubscribe anytime.